title: Stromelysin-1 expression is activated in vivo by Ets-1 through palindromic head-to-head Ets binding sites present in the promoter.
abstract: Regulation of the gene expression of Stromelysin-1 (matrix metalloproteinase-3), a member of the matrix metalloproteinase family, is critical for tissue homeostasis. The Stromelysin-1 promoter is known to be transactivated by Ets proteins through palindromic head-to-head Ets binding sites (EBS), an unusual configuration among metalloproteinase promoters. Patterns of increased co-expression of Stromelysin-1 and Ets-1 genes have been observed in pathological processes such as rheumatoid arthritis, glomerulonephritis and tumor invasion. In this context, we show in a synovial fibroblastic model cell line (HIG-82), which is able to co-express Stromelysin-1 and Ets-1, that the EBS palindrome is essential for the expression of Stromelysin-1. More precisely, using electrophoretic mobility shift assays, DNA affinity purification and chromatin immunoprecipitation, we demonstrate that endogenous Ets-1, but not Ets-2, is present on this palindrome. The use of a dominant-negative form of Ets-1 and the decrease of Ets-1 amount either by fumagillin, an antiangiogenic compound, or by short interfering RNA show that the activation rate of the promoter and the expression of Stromelysin-1 correlate with the level of endogenous Ets-1. Thus, it is the first demonstration, using this cellular model, that endogenously expressed Ets-1 is actually a main activator of the Stromelysin-1 promoter through its effective binding to the EBS palindrome.
authors.affiliation: CNRS Unité Mixte de Recherche 8526, Institut de Biologie de Lille, Institut Pasteur de Lille, Université de Lille II, Lille Cedex, France.
authors.forename: D
authors.initials: D
authors.lastname: Baillat
authors.forename: G
authors.initials: G
authors.lastname: Leprivier
authors.forename: D
authors.initials: D
authors.lastname: Régnier
authors.forename: N
authors.initials: N
authors.lastname: Vintonenko
authors.forename: A
authors.initials: A
authors.lastname: Bègue
authors.forename: D
authors.initials: D
authors.lastname: Stéhelin
authors.forename: M
authors.initials: M
authors.lastname: Aumercier
mesh_terms: D000818:Animals; D001483:Base Sequence; D001665:Binding Sites; D002460:Cell Line; D002843:Chromatin / Q000235:genetics / Q000502:physiology; D003510:Cyclohexanes; D004789:Enzyme Activation; D005231:Fatty Acids, Unsaturated / Q000494:pharmacology; D005347:Fibroblasts / Q000201:enzymology; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects; D005822:Genetic Vectors; D019278:Matrix Metalloproteinase 3 / Q000235:genetics*; D051379:Mice; D011401:Promoter Regions, Genetic; D050784:Proto-Oncogene Protein c-ets-1 / Q000235:genetics / Q000378:metabolism*; D011817:Rabbits; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012717:Sesquiterpenes
chemical_list: D002843:Chromatin; D003510:Cyclohexanes; D005231:Fatty Acids, Unsaturated; D050784:Proto-Oncogene Protein c-ets-1; D012717:Sesquiterpenes; C026211:fumagillin; D019278:Matrix Metalloproteinase 3